Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 5.0MG | Updated Report | 2019-04-18 | 30025 |
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 5.0MG | Updated Report | 2019-04-18 | 64287 |
| JAMP-ROPINIROLE | JAMP PHARMA CORPORATION | Actual shortage | 1.0MG | Updated Report | 2019-04-18 | 64282 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 15MG | Updated Report | 2019-04-18 | 70089 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 45MG | Updated Report | 2019-04-18 | 30031 |
| JAMP-PIOGLITAZONE | JAMP PHARMA CORPORATION | Actual shortage | 30MG | Updated Report | 2019-04-18 | 30028 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 600MG | Updated Report | 2019-04-18 | 64276 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 300MG | Updated Report | 2019-04-18 | 64271 |
| JAMP-OXCARBAZEPINE | JAMP PHARMA CORPORATION | Actual shortage | 150MG | Updated Report | 2019-04-18 | 64268 |
| JAMP-LOSARTAN | JAMP PHARMA CORPORATION | Actual shortage | 25MG | Updated Report | 2019-04-18 | 64259 |
| JAMP-LOSARTAN | JAMP PHARMA CORPORATION | Actual shortage | 25MG | Updated Report | 2019-04-18 | 64256 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 750MG | Updated Report | 2019-04-18 | 64250 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 500MG | Updated Report | 2019-04-18 | 64240 |
| JAMP-LEVETIRACETAM | JAMP PHARMA CORPORATION | Actual shortage | 250MG | Updated Report | 2019-04-18 | 64233 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 32MG | Updated Report | 2019-04-18 | 64208 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 16MG | Updated Report | 2019-04-18 | 64203 |
| JAMP-CANDESARTAN | JAMP PHARMA CORPORATION | Actual shortage | 8MG | Updated Report | 2019-04-18 | 64195 |
| ALVESCO | ASTRAZENECA CANADA INC | Anticipated shortage | 100MCG | Updated Report | 2019-04-18 | 80526 |
| DOSTINEX | PFIZER CANADA ULC | Actual shortage | 0.5MG | Updated Report | 2019-04-18 | 73569 |
| EMEND TRI-PACK | MERCK CANADA INC | Anticipated shortage | 125MG 80MG | New Report | 2019-04-18 | 81989 |
| APO-MONTELUKAST | APOTEX INC | Actual shortage | 10MG | Updated Report | 2019-04-18 | 78529 |
| APO-VENLAFAXINE XR | APOTEX INC | Actual shortage | 75.0MG | New Report | 2019-04-18 | 82022 |
| APO-ROSUVASTATIN | APOTEX INC | Actual shortage | 40MG | New Report | 2019-04-18 | 82019 |
| APO-OLOPATADINE | APOTEX INC | Actual shortage | 0.1% | New Report | 2019-04-18 | 82016 |
| APO-ATORVASTATIN | APOTEX INC | Actual shortage | 10MG | New Report | 2019-04-18 | 82013 |
| ENGERIX-B | GLAXOSMITHKLINE INC | Actual shortage | 10MCG | Updated Report | 2019-04-18 | 75189 |
| ENGERIX-B | GLAXOSMITHKLINE INC | Actual shortage | 20MCG | Updated Report | 2019-04-18 | 6511 |
| VEPESID | BRISTOL-MYERS SQUIBB CANADA | Anticipated shortage | 50MG | Updated Report | 2019-04-18 | 70228 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-04-18 | 80332 |
| LACTATED RINGERS INJ USP | BAXTER CORPORATION | Actual shortage | 310MG 20MG 30MG 600MG | Updated Report | 2019-04-18 | 80329 |
| OLMETEC PLUS | MERCK CANADA INC | Anticipated shortage | 12.5MG 40MG | Updated Report | 2019-04-18 | 80241 |
| ACUVAIL | ALLERGAN INC | Actual shortage | 0.45% | Updated Report | 2019-04-18 | 78953 |
| BLEPHAMIDE OPHT SUSPENSION | ALLERGAN INC | Actual shortage | 0.2% 10% | Updated Report | 2019-04-18 | 77342 |
| SODIUM BICARBONATE INJECTION USP | PFIZER CANADA ULC | Resolved | 84MG | Updated Report | 2019-04-18 | 63388 |
| PRALUENT | SANOFI-AVENTIS CANADA INC | Resolved | 75MG | Updated Report | 2019-04-18 | 80305 |
| MONTELUKAST | SANIS HEALTH INC | Anticipated shortage | 4MG | New Report | 2019-04-18 | 81981 |
| MONTELUKAST | SANIS HEALTH INC | Anticipated shortage | 5MG | New Report | 2019-04-18 | 81977 |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Resolved | 20MG | Updated Report | 2019-04-18 | 55204 |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Resolved | 40MG | Updated Report | 2019-04-18 | 55210 |
| CANDESARTAN | PRO DOC LIMITEE | Resolved | 16MG | Updated Report | 2019-04-18 | 76852 |
| ERGONOVINE MALEATE INJECTION | TELIGENT OU | Resolved | 0.25MG | Updated Report | 2019-04-18 | 78235 |
| MED-EXEMESTANE | GENERIC MEDICAL PARTNERS INC | Resolved | 25MG | Updated Report | 2019-04-18 | 78935 |
| NEVANAC | NOVARTIS PHARMACEUTICALS CANADA INC | Resolved | 0.1% | Updated Report | 2019-04-18 | 79161 |
| LIPIDIL SUPRA | BGP PHARMA ULC | Actual shortage | 160MG | Updated Report | 2019-04-18 | 80463 |
| PHENOBARB | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Resolved | 60MG | Updated Report | 2019-04-17 | 70690 |
| APO-FENO-SUPER | APOTEX INC | Actual shortage | 100MG | Updated Report | 2019-04-17 | 15268 |
| APO-LOSARTAN | APOTEX INC | Actual shortage | 100MG | Updated Report | 2019-04-17 | 70523 |
| OLMETEC | MERCK CANADA INC | Actual shortage | 20MG | Updated Report | 2019-04-17 | 78421 |
| METADOL-D | PALADIN LABS INC | Actual shortage | 10MG | Updated Report | 2019-04-17 | 73749 |
| ZITHROMAX FOR INTRAVENOUS INJECTION | PFIZER CANADA ULC | Actual shortage | 500MG | Updated Report | 2019-04-17 | 72813 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| STATEX SYRUP 1MG/ML | PALADIN LABS INC | To be discontinued | 1MG | New Report | 2019-04-18 | 81996 |
| STATEX DPS 50MG/ML | PALADIN LABS INC | Discontinued | Updated Report | 2019-04-18 | 81954 | |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Discontinued | 20MG | Updated Report | 2019-04-18 | 81926 |
| RIVA-OLMESARTAN | LABORATOIRE RIVA INC | Discontinued | 40MG | Updated Report | 2019-04-18 | 81929 |
| ULTRAVIST 240 | BAYER INC | Discontinued | 50% | New Report | 2019-04-17 | 81959 |
